Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.2626 | 0.4872 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0059 | 0.3556 | 0.3893 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0123 | 0.9135 | 0.9135 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0035 | 0.1438 | 0.1438 |
Brugia malayi | hypothetical protein | 0.0035 | 0.1438 | 0.2669 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.539 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0033 | 0.1276 | 0.2367 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0059 | 0.3556 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.008 | 0.539 | 0.5 |
Schistosoma mansoni | thyroid hormone receptor | 0.0133 | 1 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0035 | 0.1438 | 0.1575 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0059 | 0.3556 | 0.5 |
Echinococcus granulosus | equilibrative nucleoside transporter | 0.008 | 0.539 | 0.59 |
Echinococcus multilocularis | equilibrative nucleoside transporter 3 | 0.0066 | 0.4169 | 0.4169 |
Onchocerca volvulus | Equilibrative nucleoside transporter, putative homolog | 0.008 | 0.539 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.2626 | 0.4872 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0123 | 0.9135 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.2626 | 0.4872 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.1276 | 0.1276 |
Brugia malayi | Nucleoside transporter family protein | 0.008 | 0.539 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0.3556 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0035 | 0.1438 | 0.1438 |
Echinococcus multilocularis | equilibrative nucleoside transporter protein | 0.008 | 0.539 | 0.539 |
Trichomonas vaginalis | equilibrative nucleoside transporter, putative | 0.008 | 0.539 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.539 | 1 |
Schistosoma mansoni | thyroid hormone receptor | 0.0133 | 1 | 1 |
Trichomonas vaginalis | equilibrative nucleoside transporter, putative | 0.008 | 0.539 | 0.5 |
Echinococcus granulosus | equilibrative nucleoside transporter 3 | 0.008 | 0.539 | 0.59 |
Schistosoma mansoni | hypothetical protein | 0.0123 | 0.9135 | 0.9135 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.2626 | 0.4872 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0059 | 0.3556 | 0.3556 |
Brugia malayi | hypothetical protein | 0.008 | 0.539 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0059 | 0.3556 | 0.3556 |
Onchocerca volvulus | Equilibrative nucleoside transporter, putative homolog | 0.008 | 0.539 | 1 |
Entamoeba histolytica | nucleoside transporter, putative | 0.008 | 0.539 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0059 | 0.3556 | 0.3556 |
Trichomonas vaginalis | equilibrative nucleoside transporter, putative | 0.008 | 0.539 | 0.5 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0059 | 0.3556 | 0.5 |
Echinococcus multilocularis | equilibrative nucleoside transporter 3 | 0.008 | 0.539 | 0.539 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.1276 | 0.2367 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0.3556 | 0.5 |
Trichomonas vaginalis | equilibrative nucleoside transporter, putative | 0.008 | 0.539 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0.3556 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.539 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.1438 | 0.1438 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.